Added to YB: 2025-06-20
Pitch date: 2025-05-04
EPIX [bearish]
ESSA Pharma Inc.
+5.52%
current return
Author Info
No bio for this author
Company Info
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
Market Cap
$75.5M
Pitch Price
$0.21
Price Target
2.25 (+1018%)
Dividend
N/A
EV/EBITDA
1.15
P/E
-2.65
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
ESSA Pharma Inc. - $EPIX
EPIX: Failed biotech trading at $1.73 vs est. $2.25/share liquidation value (9/30/25). Strategic review dragging 6+ months. Two largest shareholders (19.7%, 5.1%) now publicly pushing for liquidation. Burns $2M/qtr, earns $1.1M interest. Risk: mgmt seeking merger for change-in-control payments vs liquidation. Catalyst: strategic review conclusion May 2025.
Read full article (7 min)